A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Econazole
Codrituzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Codrituzumab.
Econazole
Icrucumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Icrucumab.
Econazole
Isatuximab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Isatuximab.
Econazole
Anetumab ravtansine
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Anetumab ravtansine.
Econazole
Gancotamab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Gancotamab.
Econazole
Setrusumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Setrusumab.
Econazole
Camrelizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Camrelizumab.
Econazole
Cemiplimab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Cemiplimab.
Econazole
Lanadelumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Lanadelumab.
Econazole
Lecanemab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Lecanemab.
Econazole
Fanolesomab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Fanolesomab.
Econazole
Galcanezumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Galcanezumab.
Econazole
Fremanezumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Fremanezumab.
Econazole
Eptinezumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Eptinezumab.
Econazole
Erenumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Erenumab.
Econazole
Burosumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Burosumab.
Econazole
Besilesomab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Besilesomab.
Econazole
Sulesomab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Sulesomab.
Econazole
Emicizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Emicizumab.
Econazole
Human cytomegalovirus immune globulin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Human cytomegalovirus immune globulin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3